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Abstract: This study investigated the effect of branched-chain amino acid (BCAA) supplementation
on recovery from eccentric exercise. Twenty males ingested either a BCAA supplement or placebo
(PLCB) prior to and following eccentric exercise. Creatine kinase (CK), vertical jump (VJ), maximal
voluntary isometric contraction (MVIC), jump squat (JS) and perceived soreness were assessed.
No significant (p > 0.05) group by time interaction effects were observed for CK, soreness, MVIC, VJ,
or JS. CK concentrations were elevated above baseline (p < 0.001) in both groups at 4, 24, 48 and 72 hr,
while CK was lower (p = 0.02) in the BCAA group at 48 hr compared to PLCB. Soreness increased
significantly from baseline (p < 0.01) in both groups at all time-points; however, BCAA supplemented
individuals reported less soreness (p < 0.01) at the 48 and 72 hr time-points. MVIC force output
returned to baseline levels (p > 0.05) at 24, 48 and 72 hr for BCAA individuals. No significant difference
between groups (p > 0.05) was detected for VJ or JS. BCAA supplementation may mitigate muscle
soreness following muscle-damaging exercise. However, when consumed with a diet consisting
of ~1.2 g/kg/day protein, the attenuation of muscular performance decrements or corresponding
plasma CK levels are likely negligible.
Keywords: BCAA; muscle damage; recovery; supplement; eccentric exercise; sports nutrition
1. Introduction
Skeletal muscle damage induced by resistance-based exercise is known to promote microdamage
in muscle fibers, which may lead to temporary increased passive tension, delayed onset muscle
soreness (DOMS), decrements in strength and force production, and increased efflux of intramuscular
proteins into the blood [1]. The degree of damage and discomfort may be compounded over time
and persist chronically, especially in individuals frequently engaging in vigorous exercise or those
completing an overreaching phase [1,2]. As such, nutritional strategies have been proposed to mitigate
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the negative effects that may be experienced following strenuous resistance exercise. Protein and amino
acid supplements, including branched-chain amino acids (BCAA), have been considered a potentially
efficacious dietary intervention [3–5]. BCAAs (i.e., leucine, isoleucine and valine) are distinct among
essential amino acids in that they are extrahepatically metabolized in skeletal muscle [6,7]. It has
been suggested that BCAA supplementation may reduce protein degradation and/or muscle enzyme
release [2,3,8], decrease skeletal muscle damage in response to intense resistance exercise [9–11], reduce
feelings of soreness [12], mitigate central fatigue [13,14] and promote subsequent recovery of muscle
function [10,15]; however, these findings remain inconclusive at present [15–17]. While underlying
mechanisms remain unclear [2,18], BCAA supplementation is a popular practice among recreational
exercisers and athletes [8,19,20] and continues to garner significant research interest. For example,
Howatson et al. [10] examined the impact of 12 days of two daily doses of 10 grams (g) of BCAA or
placebo in trained males who completed a workout consisting of 100 drop-jumps. In comparison to
placebo, plasma creatine kinase (CK), perceived soreness and force production were all improved for
the first 24 hr while soreness remained significantly lower up to 48 hr after damaging exercise in the
BCAA supplemented group. No differences were noted for vertical jump. In addition, Sharp and
colleagues [11] supplemented eight recreationally active men with either a placebo or 6 g of BCAA for
three weeks and reported a reduction in CK levels 12 and 36 hr after completing two days of intense
resistance exercise. Jackman and investigators [15] reported that compared to placebo treatment, 29.2 g
of BCAA per day resulted in decreased DOMS at 48 and 72 hr in 24 non-resistance trained males after
unilateral eccentric exercise. However, no differences in percent change for electrically stimulated
maximal isometric force of the quadriceps, plasma CK, myoglobin and interleukin-6 response between
groups post-exercise were observed. Further, Foure et al. [16] found that muscle soreness and MVIC in
26 recreationally active men were not affected by 0.1 g/kg of BCAA ingested pre- and post-damaging
neuromuscular electrostimulation exercise.
Results surrounding the ability of BCAAs to favorably impact recovery from damaging exercise
are mixed. While a multitude of reasons for these inconsistencies exist, controlling for dietary
protein intake seems to be an area that previous research has not adequately considered. In this
respect, Howatson et al. [10] reported significant improvements in force production, circulating
CK levels and perceived soreness, but daily protein intake was not controlled which could have
resulted in discrepancies in overall amino acid intake. Moreover, Sharp and colleagues [11] also
reported positive outcomes for BCAA supplementation, but individuals who were consuming a daily
protein intake above the recommended daily allowance (0.8 g/kg/day) were excluded from the study.
Foure et al. [16] reported no difference between BCAA and placebo in soreness and force production.
Of note, participants in the Foure et al. investigation who were supplemented with BCAAs consumed
significantly greater quantities of daily protein on supplementation days, 1.5 g/kg/day, while the
protein intake for the placebo group averaged 1.07 g/kg/day. Finally, Jackman et al. [15] reported only
reductions in soreness when individuals were supplemented with 29.2 g of BCAAs per day or a placebo
after a damaging bout of exercise. Notably, daily protein intake in the Jackman study was controlled at
1.5 g/kg/day for subjects in both BCAA and placebo groups which may have influenced their final
outcomes. Therefore, it seems possible that when BCAA supplementation is provided while daily
protein intake is not already at recommended levels [21,22], the potential for BCAA administration to
afford any additional impact may be improved.
As it stands, the inconsistencies documented in numerous investigations following damaging
resistance exercise and subsequent recovery prevents any conclusive inferences regarding the efficacy
of BCAA supplementation. Curiously, BCAA supplementation has still been associated with reduced
perceived soreness following intense resistance exercise [5,15,23], though mechanisms explaining the
relationship between BCAA ingestion and perception of muscle soreness are not well established.
Moreover, current evidence suggests the attenuation of DOMS [5,15,24], as well as efflux of biochemical
markers of muscle damage in individuals supplementing with BCAA [5,10,11], do not necessarily occur
with a concomitant enhancement of muscle function recovery [4,5,15]. Adding to this complexity are
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the discrepancies in training state of study participants, damaging exercise protocols and overall protein
intake employed within the limited number of studies completed. Finally, the population most apt to
supplement with BCAA to attenuate the negative effects of intense resistance exercise are resistance
training individuals who are likely already ingesting a moderate protein intake (1.4–2.0 g/kg/day) [21],
thus potentially making exogenous BCAA consumption superfluous. For these reasons, the present
study aimed to investigate the effects of BCAA supplementation on markers of muscle damage and
recovery of muscle function in resistance trained males while adhering to a protein intake slightly
lower than the recommended range for resistance training individuals.
2. Materials and Methods
2.1. Participants
Twenty young, resistance-trained (RT) males (age 22.3 ± 1.5 year, height 175.4 ± 6.7 cm and
body mass 86.4 ± 15.6 kg) were recruited for the study. The present study was approved by the
institution’s Human Research Review Committee. Participants were made aware of all procedures’
risks and benefits, gave written consent and completed health history, diet history and physical
activity questionnaires. All participants had several years (5.3 ± 2.5 year) of resistance exercise
training experience, with an average self-reported training time of 7.3 ± 2.1 hr per week. Participants
were excluded if they were consuming creatine (within the past six months) and certain medications
(non-steroidal anti-inflammatory or steroidal drugs). Individuals consuming protein supplements
(e.g., whey, casein) were asked to refrain from taking these supplements following enrollment into
the study. Individuals utilizing treatments such as cryotherapy or massage, past or current smokers,
those without at least one year of current resistance training experience and participants who had
completed high volumes of unaccustomed lower-body resistance-based exercise in the last six months
(to control for the repeated bout effect) [9] were also excluded from the study. Further, all included
participants refrained from exercise and alcohol consumption 48 hr prior to testing and throughout
the entire testing period and caffeine 12 hr prior to each visit. Participant characteristics are shown in
Table 1.
Table 1. Participant characteristics.
Characteristic BCAA PLCB
Participant # 10 10
Age (yr) 23.0 ± 1.2 21.5 ± 1.5
Height (cm) 177.6 ± 7.1 173.2 ± 6.2
Body Mass (kg) 86.6 ± 15.2 86.2 ± 16.8
Body Fat% 12.3 ± 3.8 11.7 ± 4.3
1RM Squat (kg) 154.8 ± 31.7 155.0 ± 32.0
RT Experience (yr) 5.6 ± 2.3 5.0 ± 1.9
RT Experience (hrs/week) 7.00 ± 2.30 7.65 ± 2.05
Protein Intake (g/kg/d) 1.29 ± 0.12 1.25 ± 0.09
Average Calorie Intake (kcal) 2555 ± 324 2638 ± 309
All values are mean ± SD. # = number of participants, yr = years, cm = centimeters, kg = kilograms, 1RM = one
repetition maximum, RT = resistance training, BCAA= branched-chain amino acid, PLCB= placebo, g/kg/d =
grams/kilogram/day during study enrollment, kcal= calorie intake per day during study enrollment, hrs/week =
hours per week.
2.2. Experimental Design
Using a randomized, double-blind, placebo-controlled research design, participants were enrolled
into either a BCAA (MusclePharm BCAA 3:1:2 watermelon powder) or PLCB group (color and
flavor matched maltodextrin) and performed one experimental muscle-damaging exercise trial.
All participants were thoroughly familiarized with the study design; specifically the diet and physical
activity log requirements, timing and procedures of blood collection, 1RM protocol, performance
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measures (i.e., vertical jump (VJ), maximal voluntary isometric contraction (MVIC), jump squat (JS))
and supplementation regimen. Figure 1 depicts the overall study design.
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Figure 1. Experimental design overview. Participants were supplemented for 8 days with either
BCAA or placebo following baseline assessment. Participants returned to the lab 96 hr following
baseline assessment.
2.3. Baseline Testing: Enrollment, 1RM, Familiarization and Dietary Counseling
On the day of baseline testing, following consent and determination of involvement, participants
first had their height and body mass measured and their body comp s tion assessed using the
skinfold technique. Participants were then ask to complete a self-selected ten-minute warm-up
followe by Smith mach ne 1RM assessment. Following 1RM assessm nt, par icipants were asked
to rest for ten- inutes and then complet a th r ugh familiarization of the countermovement VJ,
MVIC of the q adriceps at 120 degrees of knee flexion (leg flexion a gle f 60◦ below the
horizontal plane), and 40% 1RM JS p rforma ce in order to eliminate any learning effec s on test
performance during data collection. Test-ret st reli bility was determined f r all performance variables
during th familiarization sess ons and was d e ed accept ble if they were g eater or equal to
r = 0.90. Such reliability has been shown to b essent al for experim ntal sensitivity to nutritional
interven ions [25]. Follo ing the completi n of 1RM asses ment and familiarization of p rformance
assessments, partici ants were counseled on supplementation, dietary require e ts, nd dietary
tracking. Participants wer asked to return 96 hr later to complete the uscle damaging protocol.
2.4. Anthropometric Measurements
Measurements of height, body mass and body fat percentage were obtained to characterize
the participants. Body mass was measured via a Tanita el ctronic scale (Model #3101, Arlington
Heights, IL, USA) to the nearest 0.1 kg. Two skinfold measurem nts on the right side of the body
were obtained from three sites (che t, abdomen and thigh) i serial fashion by the same investigator
utilizing Lang Calipers (Ca bridge Scientific Industries, Cambridge, MD, USA). Skinfold thickness
was based on the av rag of the two trials. If the two skinfold measurements for a particular site
varied by more t an 0.5 millimeters (mm), the technician obtai ed a third measu ement nd the mean
value of the two clo est easurements was used. Body density was th c lculat d according t the
Jackson and Pollock 3-site prediction equation [26] and percent body fat was estimated accordi g to
Siri [27]. The ethnic make-up of our partici ants consisted of sixteen Caucasian a d four Hispanic
males. Curr ntly, no population specifi -equation to estimate per ent body fat fo ispa ics exist .
The efore, the Siri equ ti was used for all participants.
Nutrients 2018, 10, 1389 5 of 15
2.5. One-Repetition Maximum (1RM)
Smith machine (Pro-Elite Strength Systems, Salt Lake City, UT, USA) back squat 1RM was
determined according to methods previously described [28]. Following a ten-minute standardized,
dynamic warm-up, each participant first performed a warm-up set of 8–10 repetitions at a light-weight
(∼50% of their estimated (est) 1RM). A second warm-up consisted of a set of 3–5 repetitions with a
moderate weight (∼75% of 1RMest) and a third warm-up included 1–3 repetitions with a heavy weight
(∼90% of 1RMest). After the warm-up, each participant’s 1RM was tested by increasing the load during
consecutive trials until the participants were unable to perform a proper lift using correct technique
(90 degrees of knee flexion). The 1RM test was determined by 4–6 sets of one repetition, with 3–5 min
of rest between attempts. Spotters were present to provide verbal encouragement and spotting to
ensure safety of the participants.
2.6. Supplementation, Diet and Diet Tracking
Participants ingested 0.22 g/kg/day of BCAA (MusclePharm, Denver, CO; 7.16 g = 3 g leucine, 1 g
isoleucine, 2 g valine) or maltodextrin (PLCB) in dry-powder form mixed with water (~175–350 mL) for
a total of 8 days following baseline assessment. The supplements were separated into one morning and
one evening dose per day. On the fifth day of supplementation, participants returned to the laboratory
and completed the muscle-damaging squat-exercise protocol. Participants were instructed to consume
their supplement prior to completing the exercise visit as well as follow-up visits. A research team
member provided each participant with specific verbal and written directions and procedures for
reporting a detailed dietary intake, including information on how to record portions using household
measures, preparation technique and nutrient content descriptors (e.g., reduced-fat, light). During
the entire experimental period (8 days), participants recorded their food intake using a paper food
log and were instructed, if needed, by a registered dietician on how to achieve a protein intake
of 1.2 g/kg/day of body mass. Further, participants were instructed to follow their normal total
calorie intake throughout the duration of the study. Participant’s dietary logs were then entered
into MyFitnessPal (Under Armour, Baltimore, MD, USA) in order to calculate macronutrient and
calorie intake.
2.7. Experimental Protocol (Muscle Damaging Exercise Visit)
Participants were asked to return to the laboratory 96 hr following baseline testing to undergo a
muscle damaging exercise protocol. Participant’s dietary logs were checked for protein compliance
upon arrival, followed by a pre-exercise blood collection, rating of perceived soreness, and assessments
of VJ, MVIC, and 40% 1RM jump squat. Participants then completed the muscle-damaging squat
exercise protocol. Following completion of the exercise protocol, participants rated their current state
of soreness and completed all measures of exercise-performance immediately post-exercise (IPE), 1, 2, 4,
24, 48 and 72 hr post-squat exercise. Participant’s blood was collected 4, 24, 48 and 72 hr post-exercise.
The same trained researcher was used for the collection of each participant’s performance measures.
2.8. Muscle Damaging Protocol
A standardized bout of resistance exercise involving ten sets of eight repetitions at 70% 1RM
squats using a Smith machine (Pro-Elite Strength Systems, Salt Lake City, UT) was completed by all
participants. Each repetition throughout the squat protocol consisted of a four-second lowering and
a one-second raising of the load monitored by a metronome and spotter. A stopwatch was started
following the last repetition of each set and participants were given three minutes of rest between
all squat sets. Following completion of the squat protocol, participants then completed five sets of
20 consecutive (10 each leg) body-weight split jump repetitions with two minutes of rest between
each set.
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2.9. Markers of Muscle Performance and Soreness
2.9.1. Vertical Jump
Maximum countermovement VJ was assessed using a Vertec device (Perform Better,
West Warwick, RI, USA). Participants were instructed to stand with their feet flat and shoulder-width
apart on the ground directly beneath the Vertec. Participants were then instructed to reach up as high as
possible with a single arm to measure standing reach height, defined as the height of the highest Vertec
vane a participant could reach. Participants were then asked to complete a countermovement jump
using both feet, while reaching up to touch the highest reachable vane. Each participant’s standing
reach height was then subtracted from the highest vane touched after the countermovement jump.
Participants were allowed three jumps, with the highest jump recorded and used for statistical analysis.
2.9.2. Maximal Voluntary Isometric Contraction
Maximum voluntary isometric (MVIC) strength of quadriceps of the dominant limb was measured
by a dynamometer (Biodex Medical Systems, System 4, Shirley, NY, USA). Participants sat upright
with the chair’s backrest inclined to 85◦, with their knee placed in 120◦ of flexion (leg flexion angle of
60◦ below the horizontal plane) [29]. The axis (i.e., lateral epicondyle of the femur) of the knee was
aligned with the rotational axis of the dynamometer. For the test, participants were asked to perform a
MVIC of the quadriceps muscles for five seconds and then rest for one minute. Participants completed
this cycle three times and the peak torque value (newton-meters) was recorded.
2.9.3. Jump Squat
Jump squat peak power (PP) was determined by taking the better of two maximal effort JS at
40% of each participant’s 1RM with one minute of rest. All JS were performed using a Smith squat
rack (Pro-Elite Strength Systems, Salt Lake City, UT, USA). The countermovement depth during the
JS was self-selected as previously described [30,31]. During the JS, subjects were asked to hold a bar
across their shoulders and keep constant downward pressure on the bar so that it would not move
independently of the body. Power production was determined via a Tendo Power Analyzer (TENDO
PSA 310; Irmo, SC, USA).
2.9.4. Perceived Soreness
Participants were asked to evaluate their perceived level of muscle soreness using a visual analog
scale. Soreness was assessed along a 10 cm scale (0 cm = no soreness, 10 cm = extreme soreness) for
each time point (pre-exercise, IPE, 1, 2, 4, 24, 48 and 72 hr post-squat exercise) by drawing a line
perpendicular to the continuum line extending from 0 to 10 cm. Soreness was evaluated by measuring
the distance of each mark from 0 and rounded up to the nearest one-tenth of a centimeter [11].
2.10. Blood Sampling and Analysis
Venous blood was collected pre-squat exercise, 4, 24, 48 and 72 hr post-exercise for the collection
of plasma. As an indirect marker of muscle damage, plasma concentrations of creatine kinase
(CK) were determined in duplicate using an enzymatic assay (Pointe Scientific, Canton, MI, USA)
and a spectrophotometer (Beckman Coulter, DU-520, Fullerton, CA, USA) at a wavelength of
340 nanometers (nm).
2.11. Statistical Analysis
Statistical tests were conducted in R (version: 3.2.2; R Foundation for Statistical Computing;
Vienna, Austria) using the ‘afex’ package (version 0.16-1). Using MVIC data generated, a post-hoc
power analysis was completed. An estimated effect (d) of the interaction effect revealed a moderate
effect of 0.61. At a sample size of 10 participants per group and delta responses for both the PLA and
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BCAA group at the 24 hr post-exercise time-point resulted in a statistical power of 0.523. Separate
mixed-effects (within-between) factorial ANOVAs (group × time) were used to assess the main and
interaction effects for each reported dependent variable. Post-hoc pairwise comparisons were then used
to investigate group differences across individual time-points with the Bonferroni adjustment applied
to correct for multiple comparisons. ANOVA models were evaluated for compliance with underlying
model assumptions. Assumptions of sphericity were tested using Mauchly’s test of sphericity and
violations were corrected using the Greenhouse-Geisser correction factor. Unpaired t-tests were used
to determine differences in years of previous resistance training experience, body mass, average study
protein and calorie intake, and 1RM back squat for BCAA and PLCB groups. The threshold for
statistical significance was set a priori at p ≤ 0.05 for all analyses.
3. Results
No significant differences in previous resistance training experience (p = 0.55), 1RM back squat
(p = 0.80) and body mass (p = 0.95) were found at baseline between groups. Further, there were no
significant differences in protein intake (g/kg/day; p = 0.42) and total calories consumed per day
(p = 0.57). All subjects successfully completed the 80 eccentric squats and 100 body-weight split jumps
(50 each leg). Four individuals (two from each group) decreased the weight by 10 lbs. (~4.55 kg)
in order to complete the eccentric squat exercise protocol (n = 2: set 6; n = 1: set 8; n = 1: set 9).
All performance measures (VJ, JS, MVIC), soreness ratings, and creatine kinase showed time effects
(p < 0.05) for both PLCB and BCAA groups indicating that the eccentric exercise protocol effectively
induced muscle damage.
3.1. Muscular Performance: Vertical Jump
Both groups demonstrated similar (p > 0.05) VJ height prior to the eccentric exercise protocol
(pre-exercise) (BCAA = 68.71± 2.90 cm; PLCB = 69.60± 5.87 cm). Vertical jump height was significantly
lower for both BCAA and PLCB groups IPE, 1, 2, 4, 24 and 48 hr post-eccentric exercise (p < 0.05);
however, there were no group or interaction effects for vertical jump performance (Figure 2).
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Figure 2. Mean (± standard deviation) jump height (cm; centimeters) pre-eccentric exercise, immediate
post (IPE), 1, 2, 4, 24, 48 and 72 hours (HR) for resistance trained men supplementing with
branched-chain amino acids (BCAA) or placebo (PLCB) (n = 20). * = significantly different from
pre-exercise (p < 0.05) for both BCAA and PLCB.
3.2. Muscular Performance: Maximal Voluntary Isometric Contraction
Both groups demonstrated similar (p > 0.05) force output prior to the eccentric exercise protocol
(pre-exercise) (BCAA = 305.3 ± 89.7; PLCB = 279.7 ± 59.9 Nm (Newton-meters)). Maximal voluntary
isometric force output was significantly lower at all post-exercise time points for the PLCB group, while
the BCAA group only displayed significantly lower values IPE, 1, 2 and 4 hr post-eccentric exercise
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(p < 0.05). Force output was not significantly different from baseline measures at 24 hr (p = 0.18; BCAA:
270.8 ± 68.8 Nm), 48 hr (p = 0.11; BCAA: 271.4 ± 45.8 Nm), or 72 hr (p = 0.21; BCAA: 295.5 ± 77.1 Nm)
and no significant group-by-time effect was observed at any of the time-points (p > 0.05) (Figure 3).
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Figure 3. ean ( standard deviation) force production ( e ton- eters) pre-eccentric exercise,
i ediate post (IPE), 1, 2, 4, 24, 48 and 72 hours (HR) for resistance trained men supplementing
with branched-chain amino acids (BCAA) or placebo (PLCB) (n = 20). * = significantly different from
pre-exercise (p < 0.05) for PLCB. ˆ = significantly different from pre-exercise (p < 0.05) for BCAA.
3.3. Muscular Performance: Jump Squat
Both groups demonstrated similar (p > 0.05) peak power output as measured by the
40% 1RM JS prior to the eccentric exercise protocol (pre-exercise) (BCAA = 1392.9 ± 344.1;
PLCB = 1439.1 ± 270.5 watts). Peak power output was significantly lower for both BCAA and PLCB
groups IPE, 1, 2, 4, 24, 48 and 72 hr following eccentric exercise (p < 0.05); however, there were no
group or interaction effects for JS performance (Figure 4).
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Figure 4. Mean (± standard deviation) peak power output (watts) pre-eccentric exercise, immediate
post (IPE), 1, 2, 4, 24, 48 and 72 hours (HR) for resistance trained men supplementing wi h
branched-chain amino cids (BCAA) or placebo (PLCB) (n = 20). * = significantly different from
pre-exercise (p < 0.05) for both BCAA and PLCB.
3.4. Muscle Soreness
Both gr ups demonstrated similar pre-exercise perceived soreness ratings (BCAA = 0 ± 0; PLCB=
0 ± 0 cm). Perceived soreness was significantly elevated for both BCAA and PLCB groups IPE, 1, 2, 4,
24, 48 and 72 hr post-eccentric exercise (p < 0.05), however the BCAA group reported significantly less
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soreness (p < 0.01) at 48 hr (BCAA: 4.59 ± 1.42; PLCB: 7.14 ± 1.65 cm) and 72 hr post-exercise (BCAA:
1.38 ± 1.83 cm; PLCB: 3.90 ± 1.52 cm) (Figure 5).
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Figure 5. Mean (± standard deviation) perceived soreness rating (cm; centimeters) pre-eccentric
exercise, immediate post (IPE), 1, 2, 4, 24, 48 and 72 hours (HR) for resistance trained men
supplementing with branched-chain amino acids (BCAA) or placebo (PLCB) (n = 20). * = significantly
different from pre-exercise for both BCAA and PLCB (p < 0.05); ˆ = significantly different from PLCB
group (p < 0.05).
3.5. Blood Parameter: Creatine Kinase
Figure 6 displays the changes in plasma CK activity over the course of the experimental period.
There were no significant differences between groups at pre-exercise (p > 0.05; BCAA = 134.5 ± 34.0;
PLCB = 117.3 ± 34.8 IU/L). Plasma CK concentrations were significantly elevated above baseline
(p < 0.001) in both BCAA and PLA groups at 4, 24, 48 and 72 hr post-exercise. While no significant
group-by-time effect was detected for plasma CK (p = 0.10), plasma CK levels were significantly lower
for the BCAA group at 48 hr post-exercise (p = 0.02; BCAA: 799.2 ± 197.6; PLCB: 1422.9 ± 630.8 IU/L).
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Figure 6. Mean (± standard deviation) plasma creatine kinase (IU/L; international units per liter)
pre-eccentric exercise, 4, 24, 48 and 72 hours (HR) for resistance trained men supplementing with
branched-chain amino acids (BCAA) or placebo (PLCB) (n = 20). * = significantly different from
pre-exercise (p < 0.001); ˆ = significantly different from PLCB group (p = 0.02).
4. Discussion
The aim of the present study was to examine the effect of BCAA supplementation on indices
of muscle damage in resistance-trained men consuming a strict protein diet intended to provide a
protein intake of 1.2 g/kg/day. To date, this is the first study examining the potential of a BCAA dose,
normalized to body mass, to mitigate damage and enhance recovery following acute squat eccentric
Nutrients 2018, 10, 1389 10 of 15
exercise in resistance-trained males undergoing strict dietary control. The ability of our eccentric squat
exercise protocol to evoke skeletal muscle damage was indirectly evaluated by post-exercise changes
in power production, isometric force loss, plasma CK concentrations and participants’ soreness ratings.
It is evident from the significant time effects [10,32,33] and magnitude of response for each of these
indices that muscle damage was inflicted [34], thus allowing us to sufficiently study recovery up to
72 hr post-exercise. To our knowledge, this eccentric exercise protocol has never been used in previous
research; however, our data support the efficacy of this protocol to induce muscle damage using a
manner of training that may be implemented into a resistance trainee’s program.
Proficient recovery procedures following strenuous, muscle-damaging exercise sessions are
important for supporting training-induced adaptation and promoting quality subsequent exercise
sessions. Amino acids have been shown to increase protein synthesis in the post-exercise period [35,36]
and their consumption by athletes and recreationally trained individuals is a common practice to
promote recovery. Research suggests greater protein synthetic rates and amino acid availability
reduces damage to myofibrillar and cytoskeletal proteins, thereby helping to preserve force production
abilities [36,37].
The muscle force generating capabilities during the recovery period following eccentric exercise
have been suggested to be one of the most reliable indices of muscle damage due to the relationship
between muscle force and muscle function [34]. Therefore, we chose to examine the effect of BCAA
supplementation on recovery of muscle force production during an MVIC of the dominant leg
quadriceps muscles as well as to evaluate recovery of more ballistic movements. While we found no
differences in vertical jump height or loaded jump squat peak power between groups, MVIC force
recovery was significantly recovered at 24, 48 and 72 hr post-exercise time-points for the BCAA
group. These findings are similar to that of Howatson and colleagues [10] who reported a significantly
lower decrement in MVIC force production and increased force production recovery in trained males
supplementing with 20 g per day (10 g twice per day of BCAA, an additional 20 g bolus one hour
pre-exercise, and another 20 gram bolus immediately post-exercise). However, the participants’ vertical
jump height was unaffected. On the other hand, Foure et al. [16] reported 7 g of BCAA per day had
no effect on recovery of quadriceps MVIC in recreationally trained males following muscle damage.
Likewise, in a study by Jackman et al. [15], no differences were detected in force producing capabilities
in untrained males supplementing with 29.3 g of BCAA per day as measured by MVIC. Kirby and
coworkers [38] examined the effect of 250 mg/kg of the BCAA leucine on recovery of force production
and vertical jump height. While no differences in jump height were detected, leucine attenuated mean
peak force decrements across all post-exercise time points (up to 96 hr) in untrained males. Similar
results from two cross-over investigations examining BCAA supplementation on recovery of muscle
function in untrained individuals reported favorable outcomes of muscle function assessments [39,40].
However, these findings may be influenced by the repeated bout phenomena and should be considered
a limitation [41,42]. While MVIC testing is a popular, valid and reliable measure of muscle function
and recovery [43], it is important to note that the isometric movement associated with MVIC testing
is distinctly different from several types of athletic performance movements. Though our data and
others’ work [10,12] suggest enhanced recovery of force production in individuals consuming BCAAs,
no studies to date provide evidence that BCAA supplementation supports recovery of more ballistic
and functional movements [10,17,38].
While our data suggest a minor impact of BCAA supplementation on muscle function during
recovery from muscle damaging exercise, the BCAA group also reported significantly less soreness
48 and 72 hr post-exercise. This is in agreement with previous work [15,44] and suggests the
relationship between muscular function and soreness is not necessarily inversely related. Even though
no improvement in muscle function was detected, untrained men consuming a diet consisting of
1.5 g/kg/day of protein and four doses of 7.3 g BCAA per day reported significantly less soreness
72 hr post eccentric exercise [15]. Similar findings by Howatson et al. [10] and Shimomura et al. [39]
were reported 24 and 48 hr post resistance-based muscle damaging exercise in individuals consuming
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20 g per day BCAA and 100 mg/kg body mass, respectively. Further, there is evidence that mixed
amino acid supplementation decreases perception of muscle soreness by 30% when ingested during
recovery from muscle-damaging exercise [5]. The mechanism(s) by which BCAA supplementation
decreases muscle soreness cannot be deduced by our experimental study design; however, it has been
suggested that enhanced glutamine production from BCAA degradation may be partly responsible
for these observations [45]. Intense eccentric exercise results in significant increases in markers of
inflammation. Previous research suggests these increases in inflammation heighten the sensitivity of
muscle nociceptors [46] and correlates with increased feelings of soreness [46,47]. Upon consumption,
transamination of some BCAAs to glutamate in order to synthesize glutamine may occur. In turn,
glutamine may be consumed by inflammatory cells under inflammatory conditions [48]. Nicastro and
colleagues [48] suggest that BCAAs decrease the inflammatory status of damaged muscle through
increased availability of amino acids as substrates for immune cells, glutamine in particular; however,
further research is needed to confirm this hypothesis.
We examined the effect of BCAA supplementation on one surrogate marker of muscle damage,
CK, during the recovery period. Efflux of CK into the blood is indicative of sarcolemma disruption [34].
Several studies suggest an effect of amino acid supplementation on CK efflux following muscle
damaging exercise [8,10,12,39]. Plasma CK following our eccentric squat protocol was significantly
elevated from pre-exercise levels in both groups; however, resistance trained men supplementing with
BCAA demonstrated significantly lower values 48 hr post-exercise when compared to the placebo
group. Though non-significant, our data show the BCAA group’s plasma CK levels were lower at all
time-points when compared to those of the placebo group and significantly lower at 48 hr. While we do
not feel the 48 hr reduction in CK is physiologically relevant to the BCAA supplementation, numerous
studies suggest amino acid supplements are effective at reducing CK efflux caused by damaging
endurance or resistance exercise [8,10,39,49]. Following an acute bout of muscle damaging exercise,
Howatson et al. [50] described significant reductions in plasma CK concentrations in well-trained,
competitive rugby and national football players supplementing with 10 g of BCAA twice daily, with an
additional 20 g prior to and immediately post-exercise. Similarly, 0.4 g/kg/day of a supplement
(Big One, Professional Dietetics, Milan, Italy; 3 divided doses daily) containing 13 amino acids,
including the BCAAs, attenuated plasma CK increases after one week of an overreaching program [51].
A report from Shimomura et al. [39] investigating untrained women completing body weight squats
and consuming 100 mg/kg BCAA prior to exercise demonstrated lower CK values compared to that
of a placebo group. Coombes and McNaughton [8] showed that increases in serum CK concentrations
following 120 min cycling at 70% of each participant’s maximal oxygen uptake were significantly
lower for the males consuming 12 g per day of BCAA with an additional 20 g consumed immediately
pre- and post-cycling exercise. Data from Ohtani and colleagues [52] demonstrated that 6.6 g/day of a
mixed amino acid supplement (BCAA, arginine, glutamine) attenuated increases in serum CK activity
during recovery from strenuous long-distance running. However, following marathon performance,
5 g/day of BCAA did not attenuate changes in myoglobin, another indirect biochemical marker
of muscle injury (e.g., sarcolemma disruption) [17]. In the only study to date examining leucine
supplementation alone on indirect measures of muscle damage, 250 mg/kg (30 min before, during and
immediately post-exercise and the morning of each recovery day following exercise) was ineffective at
attenuating increases in CK and myoglobin in untrained males who completed an acute bout of muscle
damaging resistive exercise [38]. While data exists to suggest BCAA supplements reduce the efflux
of CK following a damaging or strenuous bout of exercise, the mechanism by which BCAAs assist
in repairing/preserving the muscle sarcolemma membrane has yet to be elucidated. Results from
several studies demonstrate that muscle cells have an efficient sarcolemma repair system to mediate
response to local damage [34]. Small tears within the sarcolemma are typically sealed within seconds in
healthy muscle. The protein dysferlin is a chief mediator of membrane resealing in muscle [53]. Future
research studies should be developed to examine the relationship between amino acid availability and
sarcolemma remodeling.
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Although we feel this study has substantial external validity, results should be interpreted
with caution as we were unable to use a cross-over study design due to the repeated bout effect
associated with eccentric exercise [54]. Also, while we included strict dietary instructions, we were
unable to prepare and administer meals for participants or control the amino acid content of each
participant’s diet. Though the recommended protein intake for this study was lower than the
recommended intake for resistance training males, we acknowledge the protein intake may have
been sufficient to promote recovery as well as understand the error associated with self-reporting
dietary intake. Future research studies should examine the effect of BCAA supplementation on
recovery of relevant ballistic and athletic movements during the post-exercise period, as well as
maximal strength assessments.
5. Conclusions
The results of this investigation demonstrate that supplementing a controlled diet of
1.2 g/kg/day of protein with 0.22 g/kg body mass/day of BCAA for eight days results in decreased
perceptions of soreness in resistance-trained individuals with several years of experience. However,
BCAA supplementation in this fashion provides a minimal protective effect on attenuating other
indirect makers of muscle damage following eccentric-based resistance exercise. While our results
suggest BCAA may aid in the maintenance of isometric muscle function following muscle damage,
this ergogenic effect may be trivial as there was no effect on dynamic measures of muscle function.
Since the majority of recreational individuals and athletes will most likely engage in subsequent
exercise sessions that consist of dynamic movements rather than isometric contractions, the ability
of BCAA supplementation to maintain force output during isometric contractions lacks applicability.
Therefore, when consumed with a diet consisting of 1.2 g/kg/day protein and presumably higher
daily protein intakes, it appears BCAA effects on muscle recovery are negligible.
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